White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk.

@article{Lnning2018WhiteBC,
  title={White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk.},
  author={Per Eystein L\onning and Elisabet Ognedal Berge and Merete Bj\ornslett and Laura Minsaas and Ranjan Chrisanthar and Hildegunn H\oberg-Vetti and C{\'e}cile Dulary and Florence Busato and Silje Bj\orneklett and Christine Eriksen and Reidun Kristin Kopperud and Ulrika Axcrona and Ben Davidson and Line Bj\orge and Gareth J. R. Evans and Anthony Howell and Helga Birgitte Salvesen and Imre Janszky and Kristian Hveem and P{\aa}l Richard Romundstad and Lars J Vatten and J{\"o}rg Tost and Anne D\orum and Stian Knappskog},
  journal={Annals of internal medicine},
  year={2018},
  volume={168 5},
  pages={326-334}
}
Background The role of normal tissue gene promoter methylation in cancer risk is poorly understood. Objective To assess associations between normal tissue BRCA1 methylation and ovarian cancer risk. Design 2 case-control (initial and validation) studies. Setting 2 hospitals in Norway (patients) and a population-based study (control participants… CONTINUE READING